| HGNC Family | Non-coding RNAs |
| Name | microRNA 3147 |
| Description | microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nAlthough none of the provided abstracts explicitly mention MIR3147, one of them describes a closely related microRNA—miR‐13147—which, like many microRNAs, may play important roles in modulating cell signaling pathways in cancer. In vulvar squamous cell carcinoma (VSCC), miR‐13147 is markedly overexpressed and its increased levels correlate with deeper tissue invasion. Functional studies show that miR‐13147 promotes malignant behaviors by accelerating cell proliferation, migration, invasion, and G1/S cell cycle progression, in part by binding directly to the 3′ untranslated region of Smad4 and thereby suppressing key components of the transforming growth factor‑β/Smad signaling pathway."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn addition, the abstracts also describe the role of interferon‑inducible guanylate binding protein 3 (GBP3) in various pathological contexts. In glioma and glioblastoma models, GBP3 is highly upregulated and drives tumor progression by inducing the expression of sequestosome‑1 (p62), which activates the ERK1/2 signaling cascade. This mechanism not only enhances cell proliferation but also contributes to chemoresistance by stabilizing STING protein and upregulating downstream effectors such as NRF2 and MGMT, ultimately reducing temozolomide‑induced apoptosis."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nFurthermore, in a model of lupus nephritis, GBP3 exerts a pro‑inflammatory role by inhibiting cell proliferation while enhancing the expression of inflammatory cytokines and pyroptosis‑related proteins. This suggests that GBP3 can also modulate inflammatory pathways and cell death mechanisms in autoimmune conditions."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "4"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nCollectively, while none of these studies directly assess MIR3147, the functional characterization of miR‑13147 in VSCC hints at the possibility that closely related microRNAs may similarly regulate key cellular processes involved in tumor progression and inflammation. Moreover, the insights into GBP3’s role in both oncogenesis and immune‐mediated pathology further underscore the complexity of interferon‑regulated networks in disease. Further investigations are needed to elucidate whether MIR3147 shares any of these regulatory properties.\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Xiu-Hua Yang, Feng Guo "}, {"type": "b", "children": [{"type": "t", "text": "miR‑3147 serves as an oncomiR in vulvar squamous cell cancer via Smad4 suppression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Med Rep (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/mmr.2018.8697"}], "href": "https://doi.org/10.3892/mmr.2018.8697"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29512734"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29512734"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Hui Xu, Lili Sun, Yanwen Zheng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "GBP3 promotes glioma cell proliferation via SQSTM1/p62-ERK1/2 axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2017.11.050"}], "href": "https://doi.org/10.1016/j.bbrc.2017.11.050"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29128363"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29128363"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Hui Xu, Jing Jin, Ying Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "GBP3 promotes glioblastoma resistance to temozolomide by enhancing DNA damage repair."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41388-022-02397-5"}], "href": "https://doi.org/10.1038/s41388-022-02397-5"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35780181"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35780181"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Zhongfeng Zhang, Wenyu Song, Run Yan "}, {"type": "b", "children": [{"type": "t", "text": "Gbp3 is associated with the progression of lupus nephritis by regulating cell proliferation, inflammation and pyroptosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Autoimmunity (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/08916934.2023.2250095"}], "href": "https://doi.org/10.1080/08916934.2023.2250095"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "37621179"}], "href": "https://pubmed.ncbi.nlm.nih.gov/37621179"}]}]}]}
|
| Synonyms | MIR-3147 |
| NCBI Gene ID | 100422939 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
MIR3147 has 228 functional associations with biological entities spanning 3 categories (molecular profile, cell line, cell type or tissue, gene, protein or microRNA) extracted from 9 datasets.
Click the + buttons to view associations for MIR3147 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR3147 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR3147 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at MIR3147 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR3147 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of MIR3147 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR3147 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of MIR3147 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles | cell types and tissues with high or low DNA methylation of MIR3147 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at MIR3147 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |